12:00 AM
 | 
Apr 11, 2011
 |  BC Week In Review  |  Company News  |  Deals

Genzyme, sanofi-aventis deal

sanofi-aventis completed its previously announced acquisition of Genzyme for $74 per share in cash, or...

Read the full 55 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >